We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current AZYO market cap is 17.7M. The company's latest EPS is USD -2.7700 and P/E is -1.17.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 12.39M | 12.67M | 13.05M | 10.3M | -4.48M |
Operating Income | -7.79M | -8.84M | -6.42M | -9.09M | -6.52M |
Net Income | -9.91M | -5.44M | -7.97M | -10.62M | -9.75M |
Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 39.04M | 42.9M | 42.68M | 47.39M | 49.19M |
Operating Income | -8.22M | -8.41M | -13.6M | -23.03M | -31.74M |
Net Income | -11.57M | -11.94M | -25.34M | -24.83M | -32.9M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 61.02M | 68.84M | 60.63M | 52.33M | 54.58M |
Total Liabilities | 71.7M | 73.87M | 72.81M | 74.46M | 84.05M |
Total Equity | -10.68M | -5.03M | -12.18M | -22.13M | -29.47M |
Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 47.74M | 44.77M | 82.81M | 67.17M | 68.84M |
Total Liabilities | 49.74M | 55.43M | 61.98M | 53.65M | 73.87M |
Total Equity | -43.41M | -55.11M | 20.83M | 13.52M | -5.03M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -16.19M | -21.43M | -5.17M | -7.56M | -12.68M |
Investing | -406k | -540k | -182k | -267k | -329k |
Financing | -5.73M | 8.54M | 148k | 129k | 10.54M |
Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -5.45M | -7.23M | -13.63M | -15.45M | -21.43M |
Investing | -190k | -577k | -640k | -369k | -540k |
Financing | 7.31M | 7.98M | 51.21M | 6.71M | 8.54M |
Market Cap | 17.7M |
Price to Earnings Ratio | -1.17 |
Price to Sales Ratio | 0.78 |
Price to Cash Ratio | 2.26 |
Price to Book Ratio | -7.62 |
Dividend Yield | - |
Shares Outstanding | 11.88M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | -19.02% |
52 Week High | 2.80 |
52 Week Low | 1.25 |
Spread (Intraday) | 0.04 (2.61%) |
Company Name | Aziyo Biologics Inc |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://www.elutia.com |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions